These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15522322)
1. Depletion of activated Vbeta8+ T cells disrupts bispecific antibody directed antitumor immunity. McConnell EJ; McLemore EC; Talac R; Joshi L; Nelson H J Surg Res; 2004 Nov; 122(1):103-12. PubMed ID: 15522322 [TBL] [Abstract][Full Text] [Related]
2. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Penna C; Dean PA; Nelson H Cancer Res; 1994 May; 54(10):2738-43. PubMed ID: 8168104 [TBL] [Abstract][Full Text] [Related]
3. T cell activation and retargeting using staphylococcal enterotoxin B and bispecific antibody: an effective in vivo antitumor strategy. Porter LE; Nelson H; Ethem Gecim I; Rice DC; Thibault C; Chapoval AI Cancer Immunol Immunother; 1997; 45(3-4):180-3. PubMed ID: 9435868 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131 [TBL] [Abstract][Full Text] [Related]
5. Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody. Rice DC; Chapoval AI; Porter L; Nelson H Cancer Immunol Immunother; 1999 Aug; 48(5):230-8. PubMed ID: 10478639 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes can be activated in situ by using in vivo activants plus F(ab')2 bispecific antibodies. Thibault C; Nelson H; Chapoval AI Int J Cancer; 1996 Jul; 67(2):232-7. PubMed ID: 8760593 [TBL] [Abstract][Full Text] [Related]
7. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. Spiekermann GM; Nagler-Anderson C J Immunol; 1998 Dec; 161(11):5825-31. PubMed ID: 9834060 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells. Shimizu M; Yamamoto A; Nakano H; Matsuzawa A Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016 [TBL] [Abstract][Full Text] [Related]
9. In vivo tumor immunotherapy by a bacterial superantigen. Ochi A; Migita K; Xu J; Siminovitch K J Immunol; 1993 Sep; 151(6):3180-6. PubMed ID: 8376773 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains. Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502 [TBL] [Abstract][Full Text] [Related]
11. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo. Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445 [TBL] [Abstract][Full Text] [Related]
12. The bispecific antibody 500A2 x 96.5 targets T-lymphocytes activated in vivo with staphylococcal enterotoxin B (SEB) against CL62 melanoma cells in vitro. Reid IM; Lundy JK; Donohue JH Surg Oncol; 1994 Oct; 3(5):279-85. PubMed ID: 7889221 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary metastases neutralization and tumor rejection by in vivo administration of beta glucan and bispecific antibody. Penna C; Dean PA; Nelson H Int J Cancer; 1996 Jan; 65(3):377-82. PubMed ID: 8575861 [TBL] [Abstract][Full Text] [Related]
14. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice. Nomizo A; Postol E; de Alencar R; Cardillo F; Mengel J Immunology; 2005 Oct; 116(2):233-44. PubMed ID: 16162272 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine. Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin B-activated T cells can be redirected to inhibit multicycle virus replication. Moran TM; Toy E; Kuzu Y; Kuzu H; Isobe H; Schulman JL J Immunol; 1995 Jul; 155(2):759-65. PubMed ID: 7608553 [TBL] [Abstract][Full Text] [Related]
17. The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy. Weiner GJ; Kostelny SA; Hillstrom JR; Cole MS; Link BK; Wang SL; Tso JY J Immunol; 1994 Mar; 152(5):2385-92. PubMed ID: 8133049 [TBL] [Abstract][Full Text] [Related]